ATS 2024 Final Program

Click on the session title to view the speakers

157

MONDAY • MAY 20

P628 Systemic Exposure Bioequivalence of Budesonide/Glycopyrrolate/Formoterol Fumarate With the Potential Next Generation Propellant Hydrofluoroolefin-1234ze Versus Hydrofluoroalkane-134a in Healthy Adults P629 Risks of Long-Term Inhaled Corticosteriod Use in COPD Management and Need to Assess Benefits Versus Risks P630 Can Patients With COPD Achieve and Maintain

P334 Fibrotic Cystic Lung Disease With Pulmonary Interstitial Cholesterol Granulomas (PICG) in Marfan Syndrome Associated Interstitial Lung Disease: A Case Report P335 A Rare Cause of Polycystic Lung Disease: Birt-Hogg-Dubé Syndrome P336 Erdheim-Chester Disease: A Case Report of Pulmonary and Vascular Involvement P337 Pulmonary Lymphangioleiomyomatosis Presenting as Pneumothorax in a Patient With Renal Angiomyolipoma: A Case Report P338 A Rare Case of Lymphangioleiomyomatosis Causing Spontaneous Pneumothorax in a Middle Aged Female P339 Cystic Lung Disease in a Postmenopausal Woman: A Case With Diagnostic Challenges P340 Case Report of Pulmonary Lymphangioleiomyomatosis Presenting as Bilateral Spontaneous Pneumothorax P341 Bilateral Spontaneous Pneumothoraces in a 25 Year Old Female P342 If at First You Don’t Succeed, Pleurodesis: A Case of Recurrent Pneumothorax in a Patient With Birt-Hogg-Dube Syndrome P343 Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax in a Pregnant Woman P344 Lymphangioleiomyomatosis; Less Rare Than Previously Reported? P345 Not Quite LAM? P346 Incidence of mTOR Inhibitor Use in Lymphangioleiomyomatosis: Retrospective Review of a Large Tertiary Referral Center P347 Management of Refractory Spontaneous Pneumothorax in a Patient With Lymphangiomeiomyomatosis P348 When a Switch of Perspective Makes the Difference: Incidental Diagnosis of Sporadic Lymphangioleiomyomatosis P349 An Unusual Case of Sporadic Lymphangioleiomyomatosis (S-LAM) in an Elderly Female P350 A Lamentful Duo: Extrapulmonary Lymphangioleiomyomatosis Complicated by Sepsis

Disease Stability With Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Dual Therapy Budesonide/Formoterol: A FULFIL Post Hoc Analysis

P631 Targeted Lung Denervation in COPD: 2-year Follow-up of the Airflow-3 Open-label Treatment Cohort

CLINICAL THEMATIC POSTER SESSION

B53 CASE REPORTS IN CYSTIC LUNG DISEASE 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P329 Chronic Bronchopulmonary Aspergillosis in the Setting of Lymphangioleiomyomatosis: A Rare Entity P330 Lymphangioleiomyomatosis: A Unique Approach When Tissue Is the Issue P331 A Case of Amyloid-associated Cystic Lung Disease P332 Screening for Lymphangioleiomyomatosis in a Case of a Young, Female, Nonsmoker With Recurrent Pneumothoraces P333 Spontaneous Pneumothorax Reveals Lymphangioleiomyomatosis in a Case of Gravid Uterus San Diego Convention Center Area D (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA